Legal status · United States
Is CJC-1295 with GHRP-6 legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. CJC-1295 with GHRP-6 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile.
CJC-1295 with GHRP-6 in the United States at a glance
| Classification | Not approved; research use only |
|---|---|
| Note | Research use only; growth hormone secretagogues are prohibited in sport at all times. |
| FDA approval status | Not approved. GHRP-6 has been studied in Cuba for tissue protection indications but holds no marketing authorisation in the United States, and the combination has never been evaluated anywhere. |
| Human studies cited | 3 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the CJC-1295 with GHRP-6 profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing CJC-1295 with GHRP-6 is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What CJC-1295 with GHRP-6 is
The same two-receptor pairing as the GHRP-2 version with the hungriest secretagogue of the group in the second slot. GHRP-6 has published human pharmacokinetics in nine male volunteers, with an elimination half-life of about 2.5 hours, against a GHRH half that either lasts days or minutes depending on which molecule is actually in the vial. Nobody has studied the blend.
GHRP-6 is the original growth hormone releasing hexapeptide and the one with the strongest appetite effect in the family. That is why it persists in this market: people who want to eat choose it deliberately, and people who do not want to eat find out about it the hard way.
Mechanism: GHRP-6 is a hexapeptide agonist at the growth hormone secretagogue receptor, the ghrelin receptor, which triggers a growth hormone pulse and also drives appetite, and at higher exposures raises cortisol and prolactin more than the newer selective agents. The GHRH analogue raises pulse amplitude at a separate receptor.
Regulatory history: Not approved. GHRP-6 has been studied in Cuba for tissue protection indications but holds no marketing authorisation in the United States, and the combination has never been evaluated anywhere.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for CJC-1295 with GHRP-6 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
CJC-1295 with GHRP-6 in other countries
Frequently asked questions
Is CJC-1295 with GHRP-6 legal in the United States?
No. CJC-1295 with GHRP-6 is not an approved medicine in the United States; its classification is "Not approved; research use only". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 3 human studies are cited on its profile. Note: Research use only; growth hormone secretagogues are prohibited in sport at all times.
Can I buy CJC-1295 with GHRP-6 in the United States?
No approved product exists to buy. In the United States CJC-1295 with GHRP-6 is classified as "Not approved; research use only", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: Research use only; growth hormone secretagogues are prohibited in sport at all times.
Is CJC-1295 with GHRP-6 FDA approved?
No. FDA status: Not approved. GHRP-6 has been studied in Cuba for tissue protection indications but holds no marketing authorisation in the United States, and the combination has never been evaluated anywhere.. Current US classification: "Not approved; research use only". On the evidence, 3 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for CJC-1295 with GHRP-6 live on its compound profile.
CJC-1295 with GHRP-6 profileThis page is general information about the regulatory status of CJC-1295 with GHRP-6 in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.